Mi ka management batao pura

| Drug | Dose | Note |
|---|---|---|
| Aspirin (ASA) | 162-325 mg chew karke | Sabko dena hai, contraindication na ho to |
| P2Y12 inhibitor (clopidogrel/ticagrelor/prasugrel) | Loading dose | Ticagrelor: 180 mg load, fir 90 mg BD |
| Anticoagulant (UFH/LMWH) | UFH: 60 units/kg IV bolus + 12 units/kg/h | Thrombolysis ya PCI dono ke saath |
| Nitroglycerin | 0.4 mg sublingual, har 5 min mein 3 baar | Hypotension ho to mat do |
| Oxygen | Sirf agar hypoxic ho (SpO2 <90%) | Routine oxygen band kar di gayi hai |
| Beta-blocker (Metoprolol) | 25 mg PO | HF, shock, advanced AV block, bronchospasm mein AVOID |
| Morphine | Pain ke liye | Caution - ongoing ischemia symptoms mask kar sakta hai |

| Drug | Dose | Note |
|---|---|---|
| UFH | 60 units/kg bolus + 12 units/kg/h | PCI aur thrombolysis dono mein |
| Enoxaparin (LMWH) | 30 mg IV bolus, fir 1 mg/kg SC BD | >75 years: bolus nahi, 0.75 mg/kg SC |
| Bivalirudin | 0.75 mg/kg bolus + 1.75 mg/kg/h | Sirf PCI mein validated |
| Fondaparinux | 2.5 mg IV, fir 2.5 mg SC daily | Thrombolysis mein preferred, PCI mein catheter thrombosis risk |
| Drug | Purpose |
|---|---|
| Aspirin 81 mg lifelong | Antiplatelet |
| P2Y12 inhibitor (1 year tak DAPT) | Post-stenting |
| Beta-blocker (Metoprolol/Carvedilol) | Mortality benefit, LV remodeling rokta hai |
| ACE inhibitor / ARB | Post-MI, especially LV dysfunction mein |
| High-intensity Statin | LDL <70 mg/dL target |
| GPIIb/IIIa inhibitor | Sirf PCI + stenting mein |
| Letter | Meaning |
|---|---|
| M | Morphine (pain ke liye) |
| O | Oxygen (sirf hypoxia mein) |
| N | Nitrates |
| A | Aspirin |
| DAPT | Dual Antiplatelet Therapy |
| Reperfusion | PCI first choice, thrombolysis second |